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ABSTRACT:
Sickle cell disease is a risk factor for invasive bacterial infections, and splenic dysfunction is believed to be the main underlying cause. We have previously shown that the liberation of heme in acute hemolysis can induce heme oxygenase-1 during granulopoiesis, impairing the ability of developing neutrophils to mount a bactericidal oxidative burst, and increasing susceptibility to bacterial infection. We hypothesised that this may also occur with the chronic hemolysis of sickle cell disease, potentially contributing to susceptibility to infections.
We found that neutrophil oxidative burst activity was significantly lower in treatment-naïve children with sickle cell disease compared to age-, gender-and ethnicity-matched controls, whilst degranulation was similar. The defect in neutrophil oxidative burst was quantitatively related to both systemic heme oxygenase-1 activity (assessed by carboxyhemoglobin concentration) and neutrophil mobilization. A distinct population of heme oxygenase-1-expressing cells was present in the bone marrow of children with sickle cell disease, but not in healthy children, with a surface marker profile consistent with neutrophil progenitors (CD49d Hi CD24 Lo CD15 Int CD16 Int CD11b
+/-
Introduction
Sickle cell disease (SCD) is an autosomal recessive disorder caused by point mutation of the β -globin gene, resulting in abnormal forms of hemoglobin that cause increased red blood cell rigidity and hemolysis. Over the next 40 years, it is estimated that 14 million births will be affected by SCD, with over 80% in Africa. 1 SCD causes considerable morbidity and premature death, 2 and is estimated to be one of the top-ten causes of life-years lost in West
Africa. 3 Among its many complications, individuals with SCD demonstrate dramatically increased susceptibility to specific bacterial infections, 4 including non-Typhoid Salmonella (NTS), Streptococcus pneumoniae and Haemophilus influenzae. [5] [6] Infection is a major cause of SCD-associated mortality worldwide, 5, 7 and splenic dysfunction is thought to be the major cause of this susceptibility. 8 By 12 months of age, three quarters of individuals with SCD exhibit either asplenism or hyposplenism, leaving them less able to mount an effective immune response to encapsulated bacteria. 9 Prior to the introduction of Pneumococcal conjugate vaccines and widespread penicillin prophylaxis, S. pneumoniae was the most common pathogen isolated from children with SCD presenting with invasive bacterial disease in higher income countries. 10 In Africa, S. pneumoniae is also frequently isolated in bacteremic children with SCD, 6 but other studies have found NTS, S. aureus and Klebsiella are common, [11] [12] [13] perhaps indicating that splenic dysfunction is not the only cause of susceptibility to infection in SCD.
(HO-1), during granulopoiesis in the bone marrow. A similar defect in neutrophil oxidative burst activity, which correlated with the extent of hemolysis, was demonstrated in children with malaria. 19 The extent of hemolysis and HO-1 induction in SCD can be greater than that seen in malaria, 20 and so we hypothesised that hemolysis-related neutrophil dysfunction might occur in SCD. 18 If this is the case, it may provide an additional explanation for susceptibility to infection. In the current study, we investigated whether neutrophil function is impaired in treatment-naïve children with SCD, and whether any such impairment is related to hemolysis and HO-1 activity. Bone marrow (up to 2mL) was collected from a limited number of subjects during "back-up" (SCD) or donation harvests (controls).
Methods

Patients and controls
Flow cytometry assays
Neutrophil oxidative burst and degranulation assays were performed as described previously, 19 with the following antibodies: Brilliant Violet-421 conjugated anti-CD11b
(Biolegend) and allophycocyanin conjugated anti-CD15 (eBioscience). Samples were analysed using a BD LSRFortessa flow cytometer and FlowJo version X.07 (Tree Star). The oxidative burst was assessed by the rhodamine fluorescence intensity (calibrated between samples using rainbow fluorescent particles (Biolegend)), which we have previously shown to be unimpaired by the presence of heme. 21 Degranulation was assessed by fold change in CD11b expression. HO-1 expression in blood was determined as described previously, 
ELISAs
Human hemopexin SimpleStep ELISA and haptoglobin ELISA kits (both Abcam), were used according to manufacturer's instructions.
Plasma Heme
Protein-bound plasma heme concentrations were determined by spectrophotometry. 
Results
We examined neutrophil oxidative burst activity in 26 children with HbSS-sickle cell disease (SCD) and 26 control subjects, frequency matched for age, gender and ethnicity (in respective order of priority). One subject from the control group was excluded after diagnosis of clinically asymptomatic HbCC disease, a pre-specified exclusion criterion. The groups were similar in terms of age and gender, although the control group had a smaller proportion of black African/ black British subjects (Table 1 ). All markers of hemolysis were significantly higher in the subjects with SCD than in the control subjects. White blood cell count and neutrophil count were also significantly higher in subjects with SCD.
All subjects, whether SCD or controls, showed a unimodal distribution of neutrophil oxidative burst response to PMA-stimulation ( Figure 1A ). Unstimulated and PMA-stimulated rhodamine fluorescence were both significantly lower in subjects with SCD than in controls, indicating lower basal production of reactive oxygen species, and impairment of the oxidative burst (Figure 1 B-C). This defect was specific, because upregulation of surface CD11b expression in response to PMA, a marker of neutrophil activation and degranulation, was similar between groups ( Figure 1D ). The defect in oxidative burst remained when analysis was restricted to subjects of black African/ black British ethnicity only (P=0.048 for unstimulated, and P=0.00018 for stimulated rhodamine fluorescence).
The extent of hemolysis in SCD is very variable (Table 1) We previously demonstrated in a mouse model that the effects of hemolysis and HO-1 induction on neutrophil oxidative burst are complex, because hemolysis-derived heme can activate the oxidative burst and contributes to the mobilisation of neutrophils from the bone marrow, whilst simultaneously inducing HO-1 in neutrophil progenitors during granulopoiesis.
It is this induction of HO-1 in bone marrow which impairs the oxidative burst capacity of the subsequently-produced mature neutrophils ( Figure 2A ). 18 As expected from this mechanism, the magnitude of the PMA-stimulated neutrophil oxidative burst did not correlate directly with the hemolytic component (r= -0.0063, P= 0.98). We therefore assessed the relationship between neutrophil oxidative burst, neutrophil count (as a marker of neutrophil mobilisation) and carboxyhemoglobin (as a systemic marker of HO-1 activity) in SCD subjects using a generalised linear model with an interaction term between carboxyhemoglobin and neutrophil count (allowing for the effect of each to be conditional on the value of the other).
All terms, including the interaction between neutrophil count and carboxyhemoglobin, were significantly associated with the magnitude of the PMA-stimulated oxidative burst (Table 2 ).
To illustrate this relationship, including the interaction of terms, we plotted the model- 
Discussion
Children with SCD are prone to bacteremia and overwhelming sepsis, risks that have been reduced, but not entirely eradicated, by antibiotic prophylaxis and modern conjugate vaccines. 2, 32 In African children with SCD, infection is thought to be the most common cause of death, and neither penicillin prophylaxis nor current vaccination regimes offer protection against one of the most common causes of bacteremia -NTS. 6 Splenic dysfunction has long been considered the most important cause of susceptibility to encapsulated bacterial infection in SCD. 5 However, children with SCD are also susceptible to infections with other organisms, including S. aureus and Klebsiella, [11] [12] [13] suggesting that splenic dysfunction may not be the only cause of susceptibility in this population. NTS bacteremia is strongly associated with other diseases which also cause severe hemolysis, particularly malaria and Oroya fever. 33 Hydroxyurea treatment of children with SCD reduces levels of hemolysis, 15 all-cause mortality, 34 and infection-related mortality, 17 suggesting a role for hemolysis in promoting susceptibility to infection in this population. We, and others, have previously shown that hemolysis increases susceptibility to NTS sepsis in a mouse model, 18, [35] [36] whereas anemia due to blood loss alone does not. 35 We demonstrated that this susceptibility to infection was dependent on hemolysis-derived heme causing induction of HO-1 during granulopoiesis, which resulted in the production of neutrophils with reduced oxidative burst capacity. 18 This neutrophil defect was found in the acute and progressive hemolysis that occurs in malaria infections in both mice and humans, 18-19 and we predicted that a similar defect might be seen in SCD.
18
The results of our current study demonstrate that impairment of the neutrophil oxidative burst occurs in children with SCD. Importantly, we assessed this in children who had never received hydroxyurea therapy, who had not received a blood transfusion within the last 4 months, and did not have intercurrent infection. We found that the extent of impairment of neutrophil function was extremely variable, with many children with SCD having values within the "normal range", but some showing less than 50% of the average in healthy controls. Whilst the magnitude of this defect is substantially less than that seen in chronic granulomatous disease, 37 when combined with hyposplenism and poor humoral immunity in young children, it may still be sufficient to increase susceptibility to some pathogens such as NTS. 38-39 Unlike S. pneumoniae, NTS are well adapted to intracellular survival through virulence mechanisms which specifically perturb the phagocyte oxidative burst, 40-41 and may have an additive effect with any defect induced by hemolysis. Thus, impairment of neutrophil oxidative burst capacity, may be a key factor explaining the well recognised, but poorly understood, phenomenon of susceptibility to NTS bacteremia and osteomyelitis in SCD.
We found evidence to support our working model (Figure 2A ) of the interacting effects of hemolysis, HO-1 activity, neutrophil mobilization and oxidative burst. Cell-free heme, released during hemolysis, promotes neutrophil mobilization from the bone marrow and can prime the oxidative burst, but also induces HO-1 in developing neutrophils which subsequently have reduced oxidative burst capacity. 18, 19, 42 The net effect on the oxidative burst of circulating neutrophils depends on the relative balance of these influences, such that the oxidative burst is most impaired when there is both high HO-1 activity (indicated by high carboxyhemoglobin concentration) and mobilization of neutrophils from the bone marrow (indicated by a high circulating neutrophil count). Others have demonstrated that immature neutrophils are increased in the peripheral circulation in SCD, indicating that there is indeed increased mobilization from the bone marrow. 43 The same authors also found that neutrophils from SCD patients exhibited enhanced resistance to apoptosis, a characteristic which could be a consequence of the cytoprotective functions of HO-1 during granulopoiesis. 44 Our model may also be influenced by the systemic inflammation of SCD, which contributes to neutrophil mobilization, 45 and may promote HO-1 induction and priming of the neutrophil oxidative burst. Interestingly, we found a unimodal distribution of the neutrophil oxidative burst in all subjects with SCD, which is in contrast to our findings in children with malaria, in whom we saw a bimodal response of each individual's neutrophils following PMA stimulation. 19 We speculate that the chronic hemolysis of steady-state SCD results in relatively uniform impairment of neutrophil function, whereas the acute and cyclical pattern of hemolysis in malaria results in a mixture of newly mobilised neutrophils with impaired oxidative burst and circulating neutrophils with normal or enhanced oxidative burst.
In keeping with our previous observations in malaria, 18 46 although it is not known whether this represents a direct effect of hydroxyurea, or perhaps more severe underlying disease in patients selected for hyroxyurea therapy.
In contrast to what we observed in circulating neutrophils, we found that HO-1 was robustly induced in a neutrophil progenitor population in the bone marrow of children with SCD. The small number of bone marrow samples is a limitation of our study, but we supplemented this with an in vitro model of neutrophilic maturation to determine whether heme-induced HO-1 expression could impair the development of normal oxidative burst capacity. The fact that HO-1 could be induced during neutrophilic maturation, and resulted in an impairment of the oxidative burst, is consistent with our proposed mechanism. Whilst neutrophilic differentiation and maturation of HL-60 cells is not identical to natural granulopoiesis in bone marrow, the observations of this study together with evidence from our previous work, make a compelling case that the impairment of the neutrophil oxidative burst in SCD is dependent on induction of HO-1 in bone marrow. Some important questions about the underlying mechanisms remain unanswered. Why does heme exert differential effects on neutrophil progenitors and circulating neutrophils? Does this perhaps relate to differences in the expression of receptors which might mediate the uptake of heme, for example CD91 which binds heme-hemopexin complexes? 47 And how does increased HO-1 expression lead to impairment of oxidative burst? Does it degrade heme which is needed for the NADPH oxidase, or do heme degradation products such as carbon monoxide drive more global changes in gene expression through oxidative conditioning? 48 In a mouse model, we found that non-heme induction of HO-1 did not cause susceptibility to NTS, whereas inhibition of HO-1 abrogated the susceptibility to NTS caused by hemolysis, together suggesting that increases in both heme uptake and degradation are necessary to produce neutrophil dysfunction. 18 Further studies will be needed to dissect the molecular mechanisms.
The suggestion that poor bactericidal activity of neutrophils may contribute to infection susceptibility in SCD is not entirely new, 49 and defects have been demonstrated in the oxidative burst response in adults with SCD, 50 although the role of hemolysis has not previously been explored. Our study confirms that this defect is seen in a very well defined group of children with HbSS SCD, and is not confounded by the effect of blood transfusion or disease modifying therapy. To our knowledge, no studies have yet investigated whether the oxidative burst response in SCD is predictive of subsequent risk or outcome of infection.
However, in mice, a similar reduction in the magnitude of the oxidative burst prior to infection, resulted in greatly diminished resistance to NTS. 18 A prospective study will be required to determine whether the extent of impairment of the oxidative burst is clinically significant. Neutrophil oxidative burst can be determined by flow cytometry relatively easily, but as we have shown it might also be predicted from routine measurement of neutrophil count and carboxyhemoglobin concentration, the latter being measurable non-invasively.
51
HO-1-dependent suppression of neutrophil reactive oxygen species (ROS) may represent an appropriate adaptive response to hemolysis. 18 Increased expression of HO-1 is associated with activation of multiple anti-oxidative response pathways, 48 ,52 although the exact mechanisms by which HO-1 induction leads to impaired neutrophil oxidative burst remain unknown. In the presence of cell-free heme, ROS produced by neutrophils may cause significant tissue damage, 47, 52 and a mechanism which senses hemolysis-derived heme and constrains the production of neutrophil ROS would be protective. In support of this, genetic polymorphisms in the promoter region of HMOX1 have been shown to influence HO-1 expression, 21 and are important modifiers of non-infectious complications of SCD.
53
However, a consequence of this adaptive response is impairment of an important mechanism of defence against bacteria, and it would be interesting to investigate whether HMOX1 promoter polymorphisms also influence susceptibility to bacterial infection in SCD.
There is considerable interest in harnessing the therapeutic potential of hemoglobin-and 
